New and Updated - Books

New & Updated

Here is a list of recently added titles to Bookshelf and updated books and releases

Recent Releases

Toxicological Profile for Hexachlorocyclohexane (HCH).

Atlanta (GA): Agency for Toxic Substances and Disease Registry (US); 2024 Mar.

Added 05-14-2024

Guidelines for Pediatric Immune Thrombocytopenia: Rapid Review [Internet].

Hui D, Barbara A, McGill SC; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Health System Readiness Report: The Availability of Privately Funded IV Infusion Clinics in Canada: Environmental Scan [Internet].

Baddeley A.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Upadacitinib (Rinvoq): CADTH Reimbursement Recommendation: Indication: For the treatment of adults and adolescents 12 years of age and older with refractory moderate to severe atopic dermatitis who are not adequately controlled with a systemic treatment (e.g., steroid or biologic) or when use of those therapies is inadvisable. Upadacitinib can be used with or without topical corticosteroids [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Ibrutinib for Chronic Graft-Versus-Host Disease: Rapid Review [Internet].

Khangura SD, Grobelna A; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

eConsult for Provider-to-Provider Consultation: Technology Review [Internet].

Peprah K, Walter M; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Intranasal Glucagon for the Treatment of Hypoglycemia: Rapid Review [Internet].

Tran K, MacDougall D; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Dapagliflozin for Chronic Kidney Disease: Rapid Review with Expert Input [Internet].

Khangura SD, Severn M; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Lorlatinib (Lorbrena): CADTH Reimbursement Review: Therapeutic area: ALK-positive locally advanced or metastatic non–small cell lung cancer [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Utilization of Cholinesterase Inhibitors for Alzheimer Disease in Canada: Technology Review [Internet].

Chang A, Vannabouathong C, Perras C; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

View More Recent Releases

Utilization of Old- Versus New-Generation Biologics for Plaque Psoriasis for Public and Private Payers in Canada: Technology Review [Internet].

Dyrda P, Vannabouathong C, Peter K, et al.; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Melatonin for the Treatment of Insomnia in Children and Adolescents: Rapid Review [Internet].

Tran K, Mahood Q; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Tralokinumab (Adtralza): CADTH Reimbursement Review: Therapeutic area: Atopic dermatitis [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Cemiplimab (Libtayo): CADTH Reimbursement Recommendation: Indication: First-line treatment of adult patients with non–small cell lung cancer (NSCLC) expressing PD-L1 (Tumour Proportion Score [TPS] ≥ 50%), as determined by a validated test, with no EGFR, ALK, or ROS1 aberrations, who have locally advanced NSCLC who are not candidates for surgical resection or definitive chemoradiation, or metastatic NSCLC [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Monitoring Patients With Psychotic Disorders for Clozapine-Induced Myocarditis or Cardiomyopathy: Rapid Review [Internet].

Lachance CC, Mierzwinski-Urban M; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Pemigatinib (Pemazyre): CADTH Reimbursement Review: Therapeutic area: Cholangiocarcinoma [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Ospemifene (Osphena): CADTH Reimbursement Recommendation: Indication: In postmenopausal women for the treatment of moderate to severe dyspareunia and/or vaginal dryness, symptoms of vulvar and vaginal atrophy, a component of genitourinary syndrome of menopause [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Systemic Thrombolysis by Alteplase for Acute Ischemic Stroke: Rapid Review with Expert Input [Internet].

Darvesh N, Butcher R; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Syphilis Screening for Adolescents and Adults: Rapid Review [Internet].

Barbara AM, Horton J; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Prasterone (Intrarosa): CADTH Reimbursement Review: Therapeutic area: Post-menopausal vulvovaginal atrophy [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Prevention and Treatment of Mpox [Internet].

McLean JR, Zucker JE, Vail RM, et al.

Baltimore (MD): Johns Hopkins University; 2024 May.

Added 05-14-2024

Removable Rigid Dressings for the Post-Operative Management of Leg Amputations: Rapid Review [Internet].

Vu T, Butcher R; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Stereotactic Ablative Radiotherapy for the Treatment of Oligometastatic Cancer: A Clinical Review as Part of a Health Technology Assessment, Version 2.0: Clinical Review [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Self-Collection of Nose and Throat Swab Samples for SARS-CoV-2 Antigen Testing: Emerging Health Technologies [Internet].

Clark M, Li Y, Mahood Q, et al.; Authors.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.

Added 05-14-2024

Long COVID Models of Care [Internet].

Chou R, Dana T, Ahmed AY, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2024 Apr. (Technical Brief, No. 45.)

Added 05-13-2024

Updated

RSS Feed

RSS Feed for New Releases

Recent Activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on